Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Harrow Inc
(NQ:
HROW
)
16.76
+0.60 (+3.71%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Harrow Inc
< Previous
1
2
3
4
5
6
Next >
Crude Oil Up 1%; M&T Bank Posts Upbeat Q2 Results
July 19, 2023
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 0.5% on Wednesday. The Dow traded up 0.53% to 35,137.16 while the NASDAQ rose 0.48% to 14,422.74. The S&P 500,...
Via
Benzinga
Why Shares of Harrow Health Are Jumping Wednesday
July 19, 2023
The company increased guidance, acquired a company, and had a stock sale.
Via
The Motley Fool
Why Harrow Health Stock Is Trading Higher Today?
July 19, 2023
Harrow Health Inc (NASDAQ: HROW) agreed to acquire the U.S. and Canadian commercial rights for Vevye (cyclosporine ophthalmic solution) 0.1%, a non‑preserved from Novaliq GmbH.
Via
Benzinga
AT&T, Carvana, Northern Trust, And Other Big Stocks Moving Higher On Wednesday
July 19, 2023
U.S. stocks traded higher, with the Dow Jones gaining over 250 points on Wednesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Harrow Health Inc. (NASDAQ: HROW) is a Stock Spotlight on 5/30
May 30, 2023
Via
Investor Brand Network
Recap: Harrow Health Q1 Earnings
May 11, 2023
Via
Benzinga
Earnings Preview For Harrow Health
May 10, 2023
Via
Benzinga
Harrow Health Inc. (NASDAQ: HROW) is a Stock Spotlight on 5/9
May 09, 2023
Via
Investor Brand Network
Harrow Health Inc. (NASDAQ: HROW) is a Stock Spotlight on 5/1
May 01, 2023
Via
Investor Brand Network
Harrow Prices $60 Million Public Offering of Common Stock
July 19, 2023
From
Harrow Health, Inc.
Via
Business Wire
Harrow Acquires Santen’s Branded Ophthalmic Portfolio
July 18, 2023
From
Harrow Health, Inc.
Via
Business Wire
Harrow Provides Select Preliminary Second Quarter 2023 Financial Guidance
July 18, 2023
From
Harrow Health, Inc.
Via
Business Wire
Harrow Announces Proposed Public Offering of Common Stock
July 18, 2023
From
Harrow Health, Inc.
Via
Business Wire
Harrow Health Inc. (NASDAQ: HROW) is a Stock Spotlight on 4/21
April 21, 2023
Via
Investor Brand Network
Harrow Health Inc. (NASDAQ: HROW) is a Stock Spotlight on 4/4
April 04, 2023
Via
Investor Brand Network
Harrow Health Inc. (NASDAQ: HROW) Climbs to New 52-Week High
March 28, 2023
Via
Investor Brand Network
Harrow Acquires U.S. and Canadian Commercial Rights to VEVYE® (Cyclosporine Ophthalmic Solution) 0.1% from Novaliq
July 18, 2023
From
Harrow Health, Inc.
Via
Business Wire
Harrow to Participate in B. Riley Securities 23rd Annual Institutional Investor Conference on May 24, 2023
May 17, 2023
From
Harrow
Via
Business Wire
NASDAQ:HROW Shareholder Notice: Investigation over Possible Breaches of Fiduciary Duties at Harrow Health, Inc
May 16, 2023
San Diego, CA -- (SBWIRE) -- 05/16/2023 -- An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Harrow Health, Inc.
Via
SBWire
Why Shares of Harrow Health Are Slumping Friday
May 12, 2023
The pharmaceutical company announced first-quarter earnings Thursday afternoon.
Via
The Motley Fool
Harrow Health Inc. (NASDAQ: HROW) is a Stock Spotlight on 3/22
March 22, 2023
Via
Investor Brand Network
Why Heron Therapeutics Shares Are Trading Lower By 34%? Here Are Other Stocks Moving In Friday's Mid-Day Session
May 12, 2023
Gainers GSI Technology, Inc. (NASDAQ: GSIT) shares surged 108% to $3.4207. GSI Technology is expected to announce financial results for its fiscal fourth quarter after the market close on May 16,...
Via
Benzinga
Harrow Announces First Quarter 2023 Financial Results
May 11, 2023
From
Harrow Health, Inc.
Via
Business Wire
Harrow to Launch FDA-Approved IHEEZO™ at the 2023 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting
May 04, 2023
From
Harrow
Via
Business Wire
Harrow Launches ILEVRO®, NEVANAC®, and MAXIDEX® in the U.S.
May 02, 2023
From
Harrow
Via
Business Wire
Harrow to Announce First Quarter 2023 Financial Results on May 11, 2023
April 27, 2023
From
Harrow
Via
Business Wire
Harrow Announces New $100 Million Secured Credit Facility with Oaktree
March 28, 2023
From
Harrow
Via
Business Wire
Why Jounce Therapeutics Shares Are Trading Higher By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session
March 27, 2023
Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares jumped 59.6% to $0.2513. Crown Electrokinetics said it has entered into an agreement with a leading infrastructure solutions provider.
Via
Benzinga
Harrow Announces Fourth Quarter and Year-End 2022 Financial Results
March 23, 2023
From
Harrow
Via
Business Wire
Earnings Scheduled For March 23, 2023
March 23, 2023
Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is likely to report earnings for its fourth quarter.
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.